Reimbursement authority NICE published draft guidance today giving a green light to the use of Columvi (glofitamab) in ...

Four-time non-Hodgkin lymphoma survivor Shell Rowe knows very well about the importance of finding the lighthearted side of ...

Know the early symptoms of Non-Hodgkin’s Lymphoma. Detecting NHL early improves treatment outcomes and survival rates. Stay ...

The survival rate of frozen eggs and embryos reaches more than 90% in good in vitro fertilization labs when a patient is ...

The use of hair straighteners and chemical relaxers may be associated with a higher incidence of pancreatic cancer, thyroid cancer, and non-Hodgkin’s lymphoma, according to a study.

New data from cohort 3 show EO2463 can be safely added to rituximab in first-line low-tumor-burden follicular lymphoma in need of treatment; All six patients responded positively ...

Kyle’s own blood was filtered to remove T-cells. In the lab, these T-cells were re-engineered into cancer killers and infused back into Kyle to hunt down every lymphoma cell. “They are like precision ...

Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphomas showed encouraging preliminary efficacy dataMT-601 ...

Preexisting autoimmune diseases are tied to shorter hospital stays and less toxicity risk in patients receiving chimeric ...

San Diego Padres chairman John Seidler announced the family is exploring "strategic options for the San Diego Padres, ...

As a four-time non-Hodgkin lymphoma survivor, Rowe, who first received her diagnosis in 2019 at the age of 20, found a sizable following online — including more than 79 million likes and 977,000 ...

ANTLER phase 1 data demonstrate efficacy and durability on par with autologous CAR-T cell therapy and safety allows for ...